Bullous and pustular mycosis fungoides

Authors

  • Candela Preti J. M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina
  • Andrea González Martínez J. M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina
  • Ana Clara Acosta J. M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina
  • Roberto Schroh J. M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina
  • Daniel Feinsilber J. M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina

Keywords:

Mycosis fungoides, blisters, pustules, CD30 positive

Abstract

Mycosis fungoides (MF) is the most common type of cutaneous T-cell lymphoma, it be can manifest in a variety of clinical and histological forms. The presence of blisters and pustules are rare forms of clinical presentation. In fact, only a few cases have been reported until this date. We present a long-term follow-up of a patient with classical MF who developed blister, pustular lesions, in addition to a cellular transformation CD30 positive concomitantly.

Author Biographies

Candela Preti, J. M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina

Dermatologist, Fellow of the Dermatology Service, Collagen Diseases Sector

Andrea González Martínez, J. M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina

Dermatologist, Fellow of the Dermatology Service, Oncology Sector

Ana Clara Acosta, J. M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina

Staff Physician, Oncology Sector

Roberto Schroh, J. M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina

Staff Physician, Head of the Dermatopathology Sector

Daniel Feinsilber, J. M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina

Head of the Dermatology Division

References

I. Beyer M, Sterry W. Linfomas cutáneos. En: Fitzpatrick TB, Golds-mith LA, Ktaz SI, et ál. Dermatología en Medicina General. Editorial Médica Panamericana, Buenos Aires, 2014:1745-1766.

II. Bosch MP, Valente E, Ruiz Lascano A, Kurpis M. Linfoma cutá-neo de células T atípico: lesiones purpúricas, hiperqueratósicas y psoriasiformes en un mismo paciente. Arch Argent Dermatol2006;56:143-146.

III. Willemze R, Jaffe E, Burg G, Cerroni L, et ál. WHO-EORT classifica-tion for cutaneous lymphomas. Blood 2005;105:3768-3785.

IV. Consenso Linfomas Primarios Cutáneos – 2007 [en línea] http://www.sad.org.ar/wp-content/uploads/2016/04/linfoma2009.pdf[consultado 9 de septiembre de 2017].

V. Borreli K, Torres Z, Flores O. Presentación clínica inusual de micosis fungoides: a propósito de 2 casos. Dermatol Venez1998;36:142-146.

VI. Kneitz H, Bröcker E, Becker J. Mycosis fungoides bullosa: a case report and review of the literature. J Med Case Rep 2010;4:78.

VII. Bowman PH, Hogan DJ, Sanusi ID. Mycosis fungoides bullosa: report of a case and review of the literature. J Am Acad Dermatol2001;45:934-939.

VIII. Kazakov DV, Burg G, Kempf W. Clinic pathological spectrum of mycosis fungoides. J Eur Acad Dermatol Venereol 2004;18:397-415.

IX. Pabsch H, Kunze J, Schaller J. Mycosis fungoides presenting as a pustular eruption. J Am Acad Dermatol 2009;61:908-909.

X. Kasugai K, Yanagishita T, Takeo T, Takahashi E, et ál. CD8-positive micosis fungoides bullosa. Eur J Dermatol 2012;22:563-564.

XI. Vergier B, de Muret A, Beylot-Berry M, Valliant L, et ál. Transfor-mation of micosis fungoides: clinicopathological and prognostic features of 45 cases. French study group o cutaneous lympho-mas. Blood 2000;95:2212-2218.

XII. Pisauri AM, Arias M, Abeldaño A. Factores pronósticos en micosis fungoide. Dermatol Argent 2015;21:16-31.

XIII. Swerdlow SH, Campo E, Pileri SA, Harris NL. The 2016 revision of the World Health Organization classification of lymphoid neo-plasms. Blood 2016;127:2375-2390.

XIV. Trautinger F, Eder J, Assaf C, Bagot M, et ál. European Organisa-tion for Research and Treatment of Cancer consensus recom-mendations for the treatment of mycosis fungoides/Sézary syn-drome – Update 2017. Eur J Cancer 2017;77: 57-74.

XV. Navi D, Raiz N, Levin Y, Sullivan N, et ál. The Stanford University ex-perience with conventional-dose, total skin electron-beam the-rapy in the treatment of generalized patch or plaque (T2) and tu-mor (T3) mycosis fungoides. Arch Dermatol. 2011;147:561-567.

XVI. Marchi E, Alinari L, Tani M, Stefoni V, et ál. Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients. Cancer 2005;104:2437-2441.

XVII. Wilcox RA. Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol2016;91:151-165.

Published

2017-12-30

Issue

Section

Original Articles